The Division works continually to improve quality of life for patients with vascular diseases. We are privileged to work with an outstanding team of faculty and community vascular specialists, cardiologists and cardiac surgeons, radiologists, podiatrists, rehabilitation specialists, basic scientists, engineers and computer scientists. Our ongoing collaborations have promoted remarkable academic and clinical productivity involving new and dramatically improved techniques for the diagnosis and treatment of vascular disease, gaining the Division international recognition as a Vascular Center of Excellence.
The faculty is distinguished by expertise in many aspects of vascular disease management, but perhaps none more so than aortic aneurysm disease. Stanford Vascular Surgeons are recognized around the world as leaders in aortic aneurysm treatment and research.
Spectrum MedTech Application Due September 24, 2020
2020 Spectrum MedTech Pilot Grants: Request for Proposals
The Spectrum MedTech Pilot Program funds projects involving medical devices and mobile technologies used for (1) therapeutic applications and (2) device-based patient-specific (or POC) diagnostic applications. Projects must have the objective of translating discoveries into novel medtech products that address unmet medical needs. More Details
Funding Amount: Up to $50,000 per year.
- Open to Stanford faculty with PI eligibility (with UTL, MCL, NTLR faculty appointments.)
- Clinical Educator (CE) faculty, clinical instructors, instructors, graduate students and post-doctoral scholars (clinical and non-clinical) are required to include a PI-eligible faculty member as co-PI on the application.
Application Due: Thursday, September 24th, 2020, 11:59pm
Questions? Contact Program Manager Ashley Dunn, MPH at firstname.lastname@example.org
"Good vascular health is the key to longevity"
Watch Elsie Ross, MD Vascular Surgeon and Eri Fukaya, MD Vascular Medicine Specialist, discuss the importance of vascular health and how to protect your vascular system.
Learn more with Stanford Health Care Heart Health Month
November 17, 2019
Watch the new Stanford Hospital Dedication
See aerial views of the new Stanford Hospital
News & Events
Due December 4, 2020
Metformin Abdominal Aortic Aneurysm Suppression Trial
Dr. Dalman's publication in the Vascular & Endovascular Review outlines the background and proposed design for his study on metformin for growth suppression in patients with small AAA.
Dr. Dalman recently received an NIH R61-33 grant to fund his Limiting AAA with Metformin (LIMIT Trial). The trial will study Metformin Abdominal Aortic Aneurysm Suppression. Patients will be enrolled starting Summer 2021.